Roche in Russia Roche.com Contacts Site Map Font size home About Roche Products Research Diseases Press center RIME (For Professionals) ... ... ... What is multiple sclerosis? What is idiopathic pulmonary fibrosis? What is hemophilia? New therapy for multiple sclerosis New therapy for multiple sclerosis Research recruitment New in oncology treatment Quiz "We are 18!" Rosh-TV Live Medical Information Service Medicines and quality Hotline for counterfeits Extending life news Moscow, October 05, 2017 Published a new instruction manual for the drug Herceptin / solution for subcutaneous administration 600 mg / 5 ml / Moscow, September 29, 2017 A new instruction has been published for the drug Xeloda / film-coated tablets, 150 mg and 500 mg / Moscow, September 29, 2017 A new instruction has been published for the drug Cymeven / lyophilisate for the preparation of a solution for infusion 500 mg / Basel, 22 September 2017 Препарат Тецентрик (атезолизумаб) компании «Рош» получил одобрение в ЕС для применения при определенном типе метастатического рака легкого и двух типах метастатического рака мочевого пузыря Базель , 22 сентября 2017 Препарат Газива компании «Рош» одобрен в ЕС в качестве первой линии терапии при распространенной фолликулярной лимфоме. Все новости Правовое соглашение Конфиденциальность © 2017 ЗАО "Рош-Москва" 09.10.2017 This website contains information for patients and specialists in the field of medicine and pharmaceuticals in Russia, and may contain information on Roche products that, for one reason or another, is not available or is not officially approved in your country. The information on this site should not be used for self-diagnosis and treatment and cannot be a substitute for an in-person consultation with a doctor.